Conformational selection in silico:: Loop latching motions and ligand binding in enzymes

被引:20
作者
Wong, Sergio [1 ]
Jacobson, Matthew P. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
关键词
docking; molecular dynamics; enzyme-substrate recognition; induced fit;
D O I
10.1002/prot.21666
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ligand binding frequently induces significant conformational changes in a protein receptor. Understanding and predicting such conformational changes represent an important challenge for computational biology, including applications to structure-based drug design. We describe an approach to this problem based on the assumption that the holo state is at least transiently populated in the absence of a ligand; this hypothesis has been referred to as "conformational selection." Here, we apply a method that tests this hypothesis on a challenging class of ligand-induced conformational changes, which we refer to as loop latching: the closing of a loop around an active site that sequesters the ligand from solvent. The method uses a combination of replica exchange molecular dynamics and a loop prediction algorithm to generate low-energy loop structures, and docking to select the conformation appropriate for binding a particular ligand. On a test set of six proteins, it yields loop structures including hololike conformations, generally below 2 angstrom RMSD from the liganded structure, for loops that span up to 15 residues. Docking serves as a stringent test of the predictions. In five of the six cases, the predicted loop conformations improve the ranks of cognate ligands relative to using the apo structure, although the results remain, in most cases, significantly worse than using a holo structure. The poses of the cognate ligands are correct in four of the six test cases, while they are correct for five of the six using a holo structure.
引用
收藏
页码:153 / 164
页数:12
相关论文
共 85 条
[1]   STRUCTURES OF APO AND COMPLEXED ESCHERICHIA-COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE [J].
ALMASSY, RJ ;
JANSON, CA ;
KAN, CC ;
HOSTOMSKA, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :6114-6118
[2]   Combining docking and molecular dynamic simulations in drug design [J].
Alonso, Hernan ;
Bliznyuk, Andrey A. ;
Gready, Jill E. .
MEDICINAL RESEARCH REVIEWS, 2006, 26 (05) :531-568
[3]   Triose-phosphate isomerase (TIM) of the psychrophilic bacterium Vibrio marinus -: Kinetic and structural properties [J].
Alvarez, M ;
Zeelen, JP ;
Mainfroid, V ;
Rentier-Delrue, F ;
Martial, JA ;
Wyns, L ;
Wierenga, RK ;
Maes, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2199-2206
[4]   Closed conformation of the active site loop of rabbit muscle triosephosphate isomerase in the absence of substrate: Evidence of conformational heterogeneity [J].
Aparicio, R ;
Ferreira, ST ;
Polikarpov, I .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 334 (05) :1023-1041
[5]   FUNCTIONALLY DIVERSE ENZYME SUPERFAMILY THAT ABSTRACTS THE ALPHA-PROTONS OF CARBOXYLIC-ACIDS [J].
BABBITT, PC ;
MRACHKO, GT ;
HASSON, MS ;
HUISMAN, GW ;
KOLTER, R ;
RINGE, D ;
PETSKO, GA ;
KENYON, GL ;
GERLT, JA .
SCIENCE, 1995, 267 (5201) :1159-1161
[6]   MOLECULAR-DYNAMICS WITH COUPLING TO AN EXTERNAL BATH [J].
BERENDSEN, HJC ;
POSTMA, JPM ;
VANGUNSTEREN, WF ;
DINOLA, A ;
HAAK, JR .
JOURNAL OF CHEMICAL PHYSICS, 1984, 81 (08) :3684-3690
[7]   Antigen recognition by conformational selection [J].
Berger, C ;
Weber-Bornhauser, S ;
Eggenberger, J ;
Hanes, J ;
Plückthun, A ;
Bosshard, HR .
FEBS LETTERS, 1999, 450 (1-2) :149-153
[8]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[9]   Protein conformer selection by ligand binding observed with crystallography [J].
Cao, Y ;
Musah, RA ;
Wilcox, SK ;
Goodin, DB ;
McRee, DE .
PROTEIN SCIENCE, 1998, 7 (01) :72-78
[10]   Protein flexibility is an important component of structure-based drug discovery [J].
Carlson, HA .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (17) :1571-1578